APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vericiguat Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vericiguat Tablets Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchVericiguat Tablets Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Vericiguat Tablets Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Vericiguat Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vericiguat Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Vericiguat Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Vericiguat Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vericiguat Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vericiguat Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vericiguat Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vericiguat Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vericiguat Tablets market include Bayer and Merck among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vericiguat Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vericiguat Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vericiguat Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vericiguat Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Vericiguat Tablets Segment by Company

Bayer

Merck

Vericiguat Tablets Segment by Type

10mg per Tablet

2.5mg per Tablet

5mg per Tablet

Vericiguat Tablets Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Vericiguat Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vericiguat Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vericiguat Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vericiguat Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Vericiguat Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vericiguat Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vericiguat Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vericiguat Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vericiguat Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vericiguat Tablets industry.

Chapter 3: Detailed analysis of Vericiguat Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vericiguat Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vericiguat Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vericiguat Tablets Industry Trends Table 2. Vericiguat Tablets Industry Drivers Table 3. Vericiguat Tablets Industry Opportunities and Challenges Table 4. Vericiguat Tablets Industry Restraints Table 5. Global Vericiguat Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vericiguat Tablets Revenue Share by Company (2021-2026) Table 7. Global Vericiguat Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Vericiguat Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Vericiguat Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Vericiguat Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vericiguat Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Vericiguat Tablets Company, Product Type & Application Table 13. Global Vericiguat Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vericiguat Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg per Tablet Table 18. Significant Companies of 2.5mg per Tablet Table 19. Significant Companies of 5mg per Tablet Table 20. Global Vericiguat Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Vericiguat Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Vericiguat Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Vericiguat Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Vericiguat Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Vericiguat Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vericiguat Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Vericiguat Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Vericiguat Tablets Sales Value Share by Type (2021-2026) Table 29. Global Vericiguat Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacy Table 31. Significant Companies of Hospital Pharmacy Table 32. Significant Companies of Online Pharmacy Table 33. Global Vericiguat Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Vericiguat Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Vericiguat Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Vericiguat Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Vericiguat Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Vericiguat Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Vericiguat Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Vericiguat Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Vericiguat Tablets Sales Value Share by Application (2021-2026) Table 42. Global Vericiguat Tablets Sales Value Share by Application (2027-2032) Table 43. Global Vericiguat Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Vericiguat Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Vericiguat Tablets Sales Market Share by Region (2021-2026) Table 46. Global Vericiguat Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Vericiguat Tablets Sales Market Share by Region (2027-2032) Table 48. Global Vericiguat Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Vericiguat Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Vericiguat Tablets Sales Value Share by Region (2021-2026) Table 51. Global Vericiguat Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Vericiguat Tablets Sales Value Share by Region (2027-2032) Table 53. Global Vericiguat Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Vericiguat Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Vericiguat Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Vericiguat Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Vericiguat Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Vericiguat Tablets Sales Market Share by Country (2021-2026) Table 59. Global Vericiguat Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Vericiguat Tablets Sales Market Share by Country (2027-2032) Table 61. Global Vericiguat Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Vericiguat Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Vericiguat Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Vericiguat Tablets Sales Value Market Share by Country (2027-2032) Table 65. Bayer Company Information Table 66. Bayer Business Overview Table 67. Bayer Vericiguat Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Bayer Vericiguat Tablets Product Portfolio Table 69. Bayer Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Vericiguat Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Merck Vericiguat Tablets Product Portfolio Table 74. Merck Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Vericiguat Tablets Distributors List Table 78. Vericiguat Tablets Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Vericiguat Tablets Product Image Figure 2. Global Vericiguat Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vericiguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vericiguat Tablets Sales (2021-2032) & (K Units) Figure 5. Global Vericiguat Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Vericiguat Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg per Tablet Image Figure 10. 2.5mg per Tablet Image Figure 11. 5mg per Tablet Image Figure 12. Global Vericiguat Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Vericiguat Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Vericiguat Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Vericiguat Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Vericiguat Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Vericiguat Tablets Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Online Pharmacy Image Figure 21. Global Vericiguat Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Vericiguat Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Vericiguat Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Vericiguat Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Vericiguat Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Vericiguat Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Vericiguat Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Vericiguat Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Vericiguat Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Vericiguat Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Vericiguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Vericiguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Vericiguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Vericiguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Vericiguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Vericiguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Vericiguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Vericiguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Vericiguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Vericiguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Vericiguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Vericiguat Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Vericiguat Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg per Tablet
  • 2.5mg per Tablet
  • 5mg per Tablet
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vericiguat Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Vericiguat Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Vericiguat Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vericiguat Tablets Market Dynamics
  1. 2.1 Vericiguat Tablets Industry Trends
  2. 2.2 Vericiguat Tablets Industry Drivers
  3. 2.3 Vericiguat Tablets Industry Opportunities and Challenges
  4. 2.4 Vericiguat Tablets Industry Restraints
3 Vericiguat Tablets Market by Company
  1. 3.1 Global Vericiguat Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Vericiguat Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Vericiguat Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Vericiguat Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Vericiguat Tablets Company Ranking (2024-2026)
  6. 3.6 Global Vericiguat Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Vericiguat Tablets Company Product Type and Application
  8. 3.8 Global Vericiguat Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vericiguat Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vericiguat Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vericiguat Tablets Market by Type
  1. 4.1 Vericiguat Tablets Type Introduction
  2. 4.1.1 10mg per Tablet
  3. 4.1.2 2.5mg per Tablet
  4. 4.1.3 5mg per Tablet
  5. 4.2 Global Vericiguat Tablets Sales Volume by Type
  6. 4.2.1 Global Vericiguat Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vericiguat Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Vericiguat Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Vericiguat Tablets Sales Value by Type
  10. 4.3.1 Global Vericiguat Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vericiguat Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Vericiguat Tablets Sales Value Share by Type (2021-2032)
5 Vericiguat Tablets Market by Application
  1. 5.1 Vericiguat Tablets Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Vericiguat Tablets Sales Volume by Application
  6. 5.2.1 Global Vericiguat Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vericiguat Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Vericiguat Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Vericiguat Tablets Sales Value by Application
  10. 5.3.1 Global Vericiguat Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vericiguat Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Vericiguat Tablets Sales Value Share by Application (2021-2032)
6 Vericiguat Tablets Regional Sales and Value Analysis
  1. 6.1 Global Vericiguat Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vericiguat Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Vericiguat Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Vericiguat Tablets Sales by Region (2027-2032)
  5. 6.3 Global Vericiguat Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vericiguat Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vericiguat Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vericiguat Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Vericiguat Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vericiguat Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Vericiguat Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vericiguat Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Vericiguat Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vericiguat Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vericiguat Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vericiguat Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Vericiguat Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vericiguat Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vericiguat Tablets Sales Value Share by Country, 2025 VS 2032
7 Vericiguat Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Vericiguat Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vericiguat Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vericiguat Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Vericiguat Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Vericiguat Tablets Sales by Country (2027-2032)
  6. 7.4 Global Vericiguat Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vericiguat Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vericiguat Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vericiguat Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vericiguat Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vericiguat Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Vericiguat Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Vericiguat Tablets Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Vericiguat Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Vericiguat Tablets Product Portfolio
  12. 8.2.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vericiguat Tablets Value Chain Analysis
  2. 9.1.1 Vericiguat Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vericiguat Tablets Sales Mode & Process
  6. 9.2 Vericiguat Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vericiguat Tablets Distributors
  9. 9.2.3 Vericiguat Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst